These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14579509)

  • 1. Web alert. The chemistry of biological processes.
    Cavalla D
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):607-8. PubMed ID: 14579509
    [No Abstract]   [Full Text] [Related]  

  • 2. Web alert. The chemistry of metabolic and toxicological processes.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 Jan; 4(1):25-6. PubMed ID: 11727319
    [No Abstract]   [Full Text] [Related]  

  • 3. Web alert. Antisense--from design to clinic.
    Cowsert LM
    Curr Opin Mol Ther; 2000 Jun; 2(3):235. PubMed ID: 11249616
    [No Abstract]   [Full Text] [Related]  

  • 4. Web alert. The chemistry of biological products.
    Cavalla D
    Curr Opin Drug Discov Devel; 2002 Mar; 5(2):189-90. PubMed ID: 11926124
    [No Abstract]   [Full Text] [Related]  

  • 5. Web alert. The chemistry of drug design and lead optimization.
    Cavalla D
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):473-4. PubMed ID: 12197305
    [No Abstract]   [Full Text] [Related]  

  • 6. Web alert. The chemistry of drug design and lead optimization.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):375-6. PubMed ID: 11727302
    [No Abstract]   [Full Text] [Related]  

  • 7. Web alert: patent information.
    Berrie MS
    Chem Biol; 1999 Nov; 6(11):R311-2. PubMed ID: 10660357
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide.
    Tarkanyi I; Horváth A; Szatmari I; Eizert H; Vámosi G; Damjanovich S; Ségal-Bendirdjian E; Aradi J
    FEBS Lett; 2005 Feb; 579(6):1411-6. PubMed ID: 15733850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and properties of ENA oligonucleotides targeted to human telomerase RNA subunit.
    Horie M; Morita K; Kawakami J; Tsutsumi S; Ando O; Koizumi M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):171-2. PubMed ID: 17150688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive inhibition of hTERT mRNA expression and telomerase activity by DNA-signal-peptide conjugates.
    Kubo T; Bakalova R; Zhelev Z; Ohba H; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2005; (49):337-8. PubMed ID: 17150771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y; Kondo S
    Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patenting adverse event information: a commentary from the patent law.
    Wagner RP
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):396-7. PubMed ID: 16739247
    [No Abstract]   [Full Text] [Related]  

  • 13. Patent alert.
    Noprman P; Whelan C; Press N
    IDrugs; 2003 Dec; 6(12):1198-1204. PubMed ID: 14712832
    [No Abstract]   [Full Text] [Related]  

  • 14. More lawyers. More bureaucrats. Less information on drug safety.
    Walker AM
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):394-5. PubMed ID: 16739244
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 16. A listing of antisense patents, 1971-1991.
    Antisense Res Dev; 1991; 1(2):219-26. PubMed ID: 1841664
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
    Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M
    Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Web alert. The chemistry of biological products.
    Cavalla D
    Curr Opin Drug Discov Devel; 2001 Mar; 4(2):168-9. PubMed ID: 11378955
    [No Abstract]   [Full Text] [Related]  

  • 19. Novelty in chemical and pharmaceutical patents: a concise overview.
    Atkinson J; Jones R
    Future Med Chem; 2011 Mar; 3(3):253-5. PubMed ID: 21446838
    [No Abstract]   [Full Text] [Related]  

  • 20. The patentability of medicinal inventions related to personalized medicine in Japan.
    Shimbo I; Cobden A; Sumikura K
    Nat Biotechnol; 2005 Nov; 23(11):1367-9. PubMed ID: 16273062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.